GlaxoSmithKline Pharma Share Price

₹ 2,710.00

+₹170.40 (6.71%)
1D
Last updated 09 Nov, 2026, 15:52 IST
NSE: GLAXO
|
Pharmaceuticals

GlaxoSmithKline Pharma Share Price Today

As of 10 Nov 2026, GlaxoSmithKline Pharma share price is ₹2,710.00. The stock opened at ₹2,560.00, compared to its previous close of ₹2,539.60. During today's trading session, GlaxoSmithKline Pharma share price moved in the range of ₹2,547.80 to ₹2,755.00, with an average price of ₹2,651.40 for the day. Looking at its last 52-week, the stock has touched a low of ₹2,088.10 and a high of ₹3,120.70. On the performance front, GlaxoSmithKline Pharma share price has increased by 9.41% over the last six months and is up 4.72% on a year-on-year basis.

Share price over the last 1 day rose from 2577.20 to 2710.20, ranging between 2577.20 and 2749.50.

₹2,547.80
6.71% up today
₹2,755.00
1D LOW
1D HIGH

GlaxoSmithKline Pharma Stock Insights

Latest Earning
Op Profit TrendUp by 42.45% QoQ
Latest Earning
Net Profit TrendUp by 41.61% QoQ
Latest Earning
Revenue TrendUp by 27.91% QoQ
Stock Performance
OutperformingBeat Nifty by 2.29 % in last 1 year
Shareholding Pattern
DIIDII decreased stake by 17.91%
Shareholding Pattern
FIIFII decreased stake by 0.80%
Technical Indicators
Volume SpikeVolume is 78.0% above 20-day average on 1 Day interval.
Technical Indicators
Price breakoutPrice has broken above resistance on 1 Day interval.
GlaxoSmithKline Pharma stock performance
Open₹2,560.00
High₹2,755.00
Low₹2,547.80
Prev. close₹2,539.60
GlaxoSmithKline Pharma trading activity
Volume8,00,450
Average traded price₹2,694.54
Last traded time03:52:22 09 Nov
Last traded quantity1

Circuit
L
H
₹2,168.00
₹3,252.00
52-week
L
H
₹2,088.10
₹3,120.70
Mkt Cap Cr
45,923.43

P/E
40.05

P/B
24.41

ROA
28.89%
ROE
60.95%

ROCE
81.14%

Quick Ratio
1.77

EV/EBITDA
26.11

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Glaxosmi. Pharma has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Glaxosmi. Pharma appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Glaxosmi. Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,57,073.3141.65.129.61%13.79%18.65%2.3124.07
Divis Laboratories3,07,147.1591.3317.0713.32%15.32%19.56%3.567.29
Torrent Pharmaceuticals1,81,625.6586.539.894.7%11.42%11.37%0.7534.68
Laurus Labs1,28,054.0099.3521.8411.58%22.11%20.91%0.6853.97
Zydus Lifesciences1,19,700.4628.134.357.63%15.1%14.86%0.9116.02
Dr. Reddy's Laboratories1,15,685.1141.922.984.79%7.21%8.58%1.3519.31
Cipla1,13,589.0639.813.216.6%8.18%10.8%2.521.44
Mankind Pharma1,09,911.3048.566.257.82%12.76%14.68%0.7425.88
Aurobindo Pharma1,03,913.2526.72.76.46%10.13%12.76%1.1512.52
Lupin91,229.9517.623.8313.08%21.65%24.54%1.4210.23

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

GlaxoSmithKline Pharma Company Background

ISIN
INE159A01016
Sector Market Cap
₹ 45,923.43 Cr

GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company has three product areas: vaccines, specialty and general medicine. Its general medicines business has a portfolio of medicines in anti-infectives, pain, vitamins medicine, nutritional, hormones, dermatologicals, respiratory and vaccines for adults and children. The Company's general medicine brands include Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, Tenovate, T-bact and Physiogel. The Company's vaccine brands include Shingrix Herpes Zoster Vaccine, Infanrix Hexa, Synflorix, Boostrix, Havrix, Menveo, Fluarix Tetra and Varilrix. Its specialty medicine brands include Nucala, Seretide, and Trelegy Ellipta. Trelegy Ellipta, single inhaler triple therapy (SITT) for chronic obstructive pulmonary disease (COPD) patients. The Subsidiary of the Company is Biddle Sawyer Limited.

GlaxoSmithKline Pharma Financial Highlights

  • Revenue: GlaxoSmithKline Pharma reported revenue of ₹3,967.03 crore in FY26 vs ₹3,895.14 crore in FY25. It showed an increase of 1.85% on a yearly basis.
  • Operating Profit: GlaxoSmithKline Pharma reported an operating profit of ₹1,406.01 crore in FY26 vs ₹1,259.88 crore in FY25. It showed an increase of 11.60% on a year-on-year basis.
  • Net Profit: GlaxoSmithKline Pharma reported a net profit of ₹1,035.98 crore in FY26 vs ₹927.58 crore in FY25. It showed an increase of 11.69% on a yearly basis.

GlaxoSmithKline Pharma Quarterly Result Highlights

  • GlaxoSmithKline Pharma reported revenue of ₹1,256.35 crore in Sep 2026, compared with ₹982.20 crore in Jun 2026, representing an increase of 27.91% on a quarter-on-quarter (QoQ) basis.
  • GlaxoSmithKline Pharma reported an operating profit of ₹459.34 crore in Sep 2026, compared with ₹322.45 crore in Jun 2026, representing an increase of 42.45% on a quarter-on-quarter (QoQ) basis.
  • GlaxoSmithKline Pharma reported a profit of ₹335.88 crore in Sep 2026, compared with ₹237.18 crore in Jun 2026, reflecting an increase of 41.61% on a QoQ basis.
  • The earnings per share (EPS) of GlaxoSmithKline Pharma stood at ₹61.15 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
75.00%
FII
4.75%
Other DII
2.41%
Retail and other
11.77%
Mutual funds
6.07%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20254.64%
Mar 20264.62%
Jun 20264.79%
Sep 20264.75%

GlaxoSmithKline Pharma Investment Returns

1 day
+6.71%

1 week
+5.24%

1 month
+6.68%

1 year
+4.72%

3 years
+86.97%

5 years
+68.34%

GlaxoSmithKline Pharma Share Price History

GlaxoSmithKline Pharma share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
09 Nov 26
₹2,560.00 / ₹2,710.00
+6.71%
08 Nov 26
₹2,529.80 / ₹2,539.60
+0.59%
06 Nov 26
₹2,502.00 / ₹2,524.80
+0.98%
05 Nov 26
₹2,549.80 / ₹2,500.20
-1.25%
Show more

GlaxoSmithKline Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹3,821.67₹3,749.21₹3,453.71₹3,251.72
Other Income₹145.36₹145.93₹122.59₹100.66
Total Revenue₹3,967.03₹3,895.14₹3,576.30₹3,352.38
Total Expenses₹2,581.65₹2,639.95₹2,616.50₹2,515.02
Profit Before Tax₹1,406.01₹1,259.88₹816.19₹836.40
Tax₹370.03₹332.30₹226.23₹228.76
Profit After Tax₹1,035.98₹927.58₹589.96₹607.64
EPS - Basic₹61.15₹54.76₹34.83₹36.05
EPS - Diluted₹61.15₹54.76₹34.83₹36.05

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,385.39₹1,255.19₹959.80₹841.49
Income before WC changes₹1,320.14₹1,186.78₹914.67₹801.49
Change in Assets₹55.14₹29.53-₹107.15₹51.14
Change in Liabilities-₹153.31₹155.30₹168.17-₹96.89
Change in WC-₹98.17₹184.83₹61.02-₹45.75
Cash flow from Operations₹903.30₹1,289.90₹582.02₹484.23
Cash flow from Investing₹396.98-₹45.80₹8.71₹807.85
Cash flow from Financing-₹737.08-₹769.42-₹561.50-₹1,543.32
Total Cash Flow₹563.20₹474.68₹29.23-₹251.25
Cash (Start of the year)₹538.85₹64.17₹34.94₹286.19
Cash (End of the year)₹1,102.05₹538.85₹64.17₹34.94

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹717.67₹698.18₹758.20₹832.32
Current Assets₹3,606.20₹3,409.88₹2,798.42₹2,494.26
Total Assets₹4,323.87₹4,108.07₹3,556.62₹3,326.58
Current Liabilities₹1,779.10₹1,905.15₹1,524.95₹1,326.37
Net Current Asset₹1,827.09₹1,504.73₹1,273.47₹1,167.89
Non-Current Liabilities₹277.35₹251.60₹254.03₹258.94
Equity Capital₹2,267.42₹1,951.31₹1,777.64₹1,741.27
Total Equity & Liabilities₹4,323.87₹4,108.07₹3,556.62₹3,326.58

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹3,790.20₹3,723.49₹3,407.25₹3,216.34
Other Income₹142.56₹142.56₹123.48₹101.51
Total Revenue₹3,932.76₹3,866.05₹3,530.73₹3,317.86
Total Expenses₹2,559.17₹2,622.31₹2,578.08₹2,484.50
Profit Before Tax₹1,376.23₹1,248.44₹809.04₹832.39
Tax₹364.40₹329.39₹224.35₹227.69
Profit After Tax₹1,011.82₹919.05₹584.69₹604.71
EPS - Basic₹59.59₹54.01₹34.51₹35.88
EPS - Diluted₹59.73₹54.24₹34.51₹35.88

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,373.59₹1,243.74₹952.65₹837.49
Income before WC changes₹1,308.77₹1,174.77₹906.51₹796.63
Change in Assets₹62.42₹22.37-₹100.82₹42.28
Change in Liabilities-₹169.67₹163.81₹165.37-₹81.30
Change in WC-₹107.25₹186.18₹64.55-₹39.02
Cash flow from Operations₹881.42₹1,280.03₹578.94₹487.94
Cash flow from Investing₹385.25-₹36.53₹14.97₹805.19
Cash flow from Financing-₹737.07-₹769.42-₹561.50-₹1,544.18
Total Cash Flow₹529.60₹474.07₹32.41-₹251.05
Cash (Start of the year)₹536.22₹62.15₹29.74₹280.79
Cash (End of the year)₹1,065.82₹536.22₹62.15₹29.74

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹731.79₹717.38₹781.96₹860.98
Current Assets₹3,543.12₹3,383.55₹2,765.84₹2,466.72
Total Assets₹4,274.91₹4,100.93₹3,547.80₹3,327.70
Current Liabilities₹1,757.11₹1,900.81₹1,510.94₹1,317.03
Net Current Asset₹1,786.01₹1,482.73₹1,254.90₹1,149.69
Non-Current Liabilities₹276.63₹250.89₹252.76₹257.67
Equity Capital₹2,241.17₹1,949.23₹1,784.09₹1,753.00
Total Equity & Liabilities₹4,274.91₹4,100.93₹3,547.80₹3,327.70
* All values are in INR Crore
GlaxoSmithKline Pharma market depth
Bid quantityBid priceAsk priceAsk quantity
455271000
0000
0000
0000
0000
Total bid quantity455
Total ask quantity0
GlaxoSmithKline Pharma technical summary
Bearish indicators4
Neutral indicators3
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
61.97
Neutral

ATR (14)
78.96
Neutral

STOCH(9,6)
83.68
Bearish

STOCH RSI (14)
100
Bearish

ADX(9)
22.98
Bearish

UO(9)
51.73
Neutral

ROC(12)
12.7
Bullish

WillR(14)
-10.95
Bearish
Period
Simple value
Exponential vaue

5D
2561.28
2588.18

10D
2542.03
2555.92

20D
2515.14
2560.22

50D
2705.34
2620.98

100D
2642.33
2615.08
Volume trend — traded volume by day
9 Nov8L
8 Nov0L
6 Nov1L
5 Nov0L
4 Nov2L
3 Nov0L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

GlaxoSmithKline Pharma
Pharmaceuticals
Add Stock
Add Another

GlaxoSmithKline Pharma Returns Calculator

Ex-date: 29 May 2026

GlaxoSmithKline Pharma Latest News

1 month ago
Tata Teleservices, GSK Pharma, MRPL shares surge amid spike in volumes; check full list
5 months ago
Bajaj Auto, Bank of India, GSK Pharma, UNO Minda dividend record date on May 29: Last day to buy for payout
Showing news item 1 of 2

GlaxoSmithKline Pharma Share Price FAQs












Please be aware that GlaxoSmithKline Pharma stock prices are subject to continuous fluctuations due to various factors.